Moreover, we provided mechanistic insight into the combination, and found that melatonin synergizes the antitumor effect of vemurafenib by inhibiting the iNOS/hTERT signaling and cancer-stem cell traits in human melanoma (Fig. 7). This evidence concerns the gene NOS2 and cancer.